Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBG2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | S1PR2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | TOR1AIP1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | QSOX2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | RBBP5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | SAPCD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | ATG2B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | BANK1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | GMPPB | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |